Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Lotte Biologics 401(K) Plan is a benefit plan reported by Lotte Biologics Usa, LLC under EIN 88-3288202 and plan number 001. The latest loaded filing year is 2023. The filing reports 250 participants and $55,783,235 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $55,783,235
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $55,783,235
- Net assets (BOY)
- $0
Income & contributions
- Employer contributions
- $2,250,284
- Participant contributions
- $4,231,037
- Total contributions
- $54,086,149
- Total income / additions
- $60,357,841
Expenses & distributions
- Benefits paid
- $4,591,663
- Administrative expenses
- -$17,057
- Total expenses
- $4,574,606
- Net increase / (decrease)
- $55,783,235